Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma

Cancer Letters(2025)10.1016/j.canlet.2025.217856Source: DataRank Database

Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma is a research paper published in Cancer Letters (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.49)OA: closedTopics (48)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Camille Daviaud ORCID,María Cecilia Lira ORCID,Kayla Hernandez-Zirofsky,Claire Vanpouille‐Box ORCID,Mara De Martino ORCID

Live enrichment

PubMed:40482909 OpenAlex:https://openalex.org/W4411049361

National Institute of Neurological Disorders and Stroke

Grant: #NS131945-01

National Cancer Institute

Grant: #CA280787-01

Brain Tumor Charity

Grant: BTC224874-01

Weill Cornell Medicine

National Institutes of Health

Uncle Kory Foundation

FWCI

0.49

Citation Percentile

0.6%

Citation Trend

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0304383525004239?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0304383525004239?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.canlet.2025.217856

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40482909

repositoryhttps://hdl.handle.net/1813/117963

Fields of Study

Cancer Immunotherapy and BiomarkersGlioma Diagnosis and TreatmentImmune cells in cancerAnimalsGlioblastomaProgrammed Cell Death 1 ReceptorMiceCTLA-4 AntigenCell Line, TumorHumansBrain NeoplasmsImmune Checkpoint InhibitorsImmunotherapyFemaleMice, Inbred C57BLInterferon Type I

MeSH Terms

Immune Checkpoint InhibitorsAnimalsBrain NeoplasmsFemaleGlioblastomaHumansImmunotherapyInterferon Type IMice, Inbred C57BLCell Line, TumorMiceCTLA-4 AntigenProgrammed Cell Death 1 Receptor

Keywords

BlockadeGlioblastomaCTLA-4ImmunityCancer researchPD-L1MedicineIrradiationImmunologyChemistryImmune systemImmunotherapyInternal medicineT cellReceptorPhysicsType I interferonRadiation TherapyImmune Checkpoint Blockers

Sustainable Development Goals

SDG 0: Zero hunger

Dual blockade of PD-1 and CTLA-4 generates long-lasting immunity against irradiated glioblastoma

FAIR Checklist

Authors (5)

Funding (6 grants)

Impact

Open Access

Topics